advertisement
Iezhitsa I 11
Showing records 1 to 11 | Display all abstracts from Iezhitsa I100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Lambuk L
Frontiers in pharmacology 2022; 13: 875662
100616 Effect of trans-resveratrol on glutamate clearance and visual behaviour in rats with glutamate induced retinal injury
Hann Yih T; Abd Ghapor AA
Experimental Eye Research 2022; 220: 109104
100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Mohd Lazaldin MA; Ahmad S
Frontiers in pharmacology 2022; 13: 875662
100616 Effect of trans-resveratrol on glutamate clearance and visual behaviour in rats with glutamate induced retinal injury
Agarwal R
Experimental Eye Research 2022; 220: 109104
100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Iezhitsa I
Frontiers in pharmacology 2022; 13: 875662
100616 Effect of trans-resveratrol on glutamate clearance and visual behaviour in rats with glutamate induced retinal injury
Razali N
Experimental Eye Research 2022; 220: 109104
100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Agarwal R
Frontiers in pharmacology 2022; 13: 875662
100616 Effect of trans-resveratrol on glutamate clearance and visual behaviour in rats with glutamate induced retinal injury
Iezhitsa I
Experimental Eye Research 2022; 220: 109104
100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Uskoković V
Frontiers in pharmacology 2022; 13: 875662
100616 Effect of trans-resveratrol on glutamate clearance and visual behaviour in rats with glutamate induced retinal injury
Mohd Ismail N
Experimental Eye Research 2022; 220: 109104
100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Mohamud R; Mohamud R
Frontiers in pharmacology 2022; 13: 875662
